To whom must a statewide standing order for Naloxone be signed by?

In the context of a statewide standing order for Naloxone, it is essential that the document is signed by an authoritative figure in public health to ensure its legitimacy and enforceability. The Chief Medical Officer typically holds the responsibility for overseeing health policies and initiatives at the state level, including the distribution and management of medications like Naloxone, which is used to reverse opioid overdoses.

Having the order signed by the Chief Medical Officer ensures that the guidelines provided are in accordance with state health regulations and standards. This role is specifically designated to promote public health and safety, making it the appropriate choice for formalizing a standing order intended to expand access to Naloxone for those at risk of opioid overdose.

Other options, such as the Chair of the Pharmacy Board or the State Governor, while they hold significant positions, do not specifically align with the direct oversight of public health practices related to Naloxone. The Director of Public Health could be a relevant position; however, the Chief Medical Officer typically has more direct authority to establish orders concerning medications and health interventions. Thus, the correctness of the choice stems from the Chief Medical Officer's unique qualifications and responsibilities in such public health policies.